THE STUDY OF HUMORAL FACTORS OF ADAPTIVE IMMUNITY IN PATIENTS WITH NON-HODGKIN’S LYMPHOMAS

  • Tillyashaykhov M. N. Republican specialized scientific-practical medical center of oncology and radiology of Ministry of health of the Republic of Uzbekistan
  • Abdiganiyeva S. R. Republican specialized scientific-practical medical center of oncology and radiology of Ministry of health of the Republic of Uzbekistan
  • Abdurakhmonov D. A. Republican specialized scientific-practical medical center of oncology and radiology of Ministry of health of the Republic of Uzbekistan
  • Tuidzhanova H. Kh. Republican specialized scientific-practical medical center of oncology and radiology of Ministry of health of the Republic of Uzbekistan
  • Isroilova F. Kh. Republican specialized scientific-practical medical center of oncology and radiology of Ministry of health of the Republic of Uzbekistan
  • Alimova S. S. Republican specialized scientific-practical medical center of oncology and radiology of Ministry of health of the Republic of Uzbekistan
Keywords: adaptive cellular immunity, humoral immunity, polychemotherapy, lymphomas, non-Hodgkin lymphoma, immunoglobulins

Abstract

It is known that humoral factors of immunity play an important function of mediators in the cascade development of the immune response and can determine the effectiveness of the final, effector reactions of cellular immunity in the inactivation and elimination of antigens. Serum concentrations of major immunoglobulins IgG, IgA, IgM in NHL were analyzed. The highest serum content of IgG and IgA was revealed in the groups of patients with virus carrier. It has been established that one of the most important humoral markers of immunity is the circulating immune complexes (CIC). It has been established that one of the most important biological functions of immunoglobulins is antigen binding and the formation of CIC. A high level of CIC in NHL may be due not only to the activation of the immune response, but also to the suppression of the mechanisms of their elimination. Therefore, based on the results obtained, with NHL there is a pronounced imbalance of humoral immunity. CIC of large and small sizes are also increased, however, the highest increase in CIC was observed in groups of patients before chemotherapy with virus-bearing. An increase in the main immunoglobulins indicates the presence of humoral imbalance, and an increase in the CIC indicates the presence of intoxication of the body either due to the decay of the tumor cells themselves and infected cells, which almost always indicates the progression of the pathological process.

References

Antoni, P.A. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2 // J. Immunother.- 2005. -Vol.28.-P.120-128.

Antony, G.K. Interleukin 2 in cancer therapy // Curr Med. Chem. 2010.-Vol.l7 (29).-P.3297-3302.

Lindeman N. et al. One patient, two lymphomas. Simultaneous primary gastric marginal zone lymphoma and primary duodenal follicular lymphoma // Arch. Pathol. Lab. Med. -2004. Vol. 128, N9.-P. 1035-1038.

Malani A.K., Gupta C., Weigand R.T. et al. Spinal Burkitt's lymphoma in adults // Clin. Lymphoma Myeloma. 2006. - Vol. 6, N 4. - P. 333-336.

Manzur A., Zaidi S. Hypopigmented mycosis fungoides in a 10-year-old boy // Dermatol. Online J. 2006. - Vol. 31, N 6. - P. 21.

Marte A., Sabatino M., Cautiero P. et al. Unexpected finding of laparoscopic appendectomy: appendix MALT lymphoma in children // Pediatr. Surg. Int. 2007. - Vol. 7. -P. 119-123.

Mawanda O.W. Aspects of epidemiological and clinical features of patients with central nervous system Burkitt's lymphoma in Kenia // East. Afr. Med. J. 2004. - Vol. 8. — P. 97103.

Mawanda O.W. Clinical characteristics of Burkitt's lymphoma seen in Kenyan patients // East. Afr. Med. J. 2004. - N 8. - P. 78-89.

Sharkey R., Karacay H., Johnson C. et al. Pretargeted versus directly targeted radioimmu-notherapy combined with anti-CD20 antybody consolidation therapy of Non-Hodgkin lymphoma // J.Nucl.Med. 2009. - Vol. 17.-P. 123-128.

Wilson W.H., Grossbard M.L., Pittaluga S. et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: A pharmacodynamic approach with high efficacy// Blood. 2002. - Vol. 99. - P. 2685-2693.

Windsor R., Stiller C., Webb D. Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years // Pediatr. Blood Cancer. — 2007. -Vol. 11.-P. 87-91.

Wrobel G., Kazanowska B., Chybicka A. et al. Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG) // Przegl. Lek. 2004. - Vol. 61, N 2. - P. 45-48.

Views:

194

Downloads:

138

Published
2019-07-31
Citations
How to Cite
Tillyashaykhov M. N., Abdiganiyeva S. R., Abdurakhmonov D. A., Tuidzhanova H. Kh., Isroilova F. Kh., & Alimova S. S. (2019). THE STUDY OF HUMORAL FACTORS OF ADAPTIVE IMMUNITY IN PATIENTS WITH NON-HODGKIN’S LYMPHOMAS. Science Review, (6(23), 13-15. https://doi.org/10.31435/rsglobal_sr/31072019/6610
Section
Medicine

Most read articles by the same author(s)